Shanghai, China

Dadi Zeng

This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Mabwell (Shanghai) Bioscience Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dadi Zeng. Retrieved from https://idiyas.com/inventor/dadi-zeng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.5

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dadi Zeng: Innovator in Bioscience

Introduction

Dadi Zeng is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of bioscience, particularly in the development of innovative therapeutic solutions. With a total of 2 patents, Zeng is recognized for his impactful work in the industry.

Latest Patents

Among his latest patents are the "TGF-BETA RII Mutant and Fusion Protein Thereof" and the "Anti-Human Trop-2 Antibody and Application Thereof." These inventions showcase his expertise in creating advanced biopharmaceuticals that have the potential to improve treatment options for various diseases.

Career Highlights

Dadi Zeng is currently employed at Mabwell (Shanghai) Bioscience Co., Ltd. His role at this innovative company allows him to collaborate with other talented professionals in the field. His work focuses on developing cutting-edge therapies that address critical health challenges.

Collaborations

Zeng has worked alongside notable colleagues such as Rongjuan Wang and Chang Zhang. Their combined efforts contribute to the advancement of bioscience and the development of new therapeutic strategies.

Conclusion

Dadi Zeng is a key figure in the bioscience sector, with a strong portfolio of patents and collaborations. His contributions are paving the way for future innovations in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…